Apple Appoints Tim Millet as Head of Blood Sugar Measurement Development Team for Apple Watch Series
Apple has announced the appointment of Tim Millet as the new head of the development team responsible for the blood sugar measurement feature in the Apple Watch series, according to reports from various foreign media outlets. Millet, who currently serves as the vice president of platform architecture, will now lead the project to develop non-invasive blood glucose measurement technology.
The development of Apple’s non-invasive blood sugar measurement technology is being carried out by XDG (Exploratory Design Group), a secretive research organization within the company. Within XDG, there are multiple projects underway, and Millet’s leadership will be crucial in advancing the development of non-invasive blood glucose measurement. This decision comes after the unfortunate passing of Bill Athas, the previous leader of the development team, at the end of last year.
With nearly two decades of experience at Apple, Millet has proven himself as a valuable asset to the company. He played a pivotal role in the successful transition to Apple Silicon by leading various teams dedicated to processor development.
Apple’s non-invasive blood sugar measurement technology relies on a silicon photonics chip that utilizes optical absorption spectroscopy. By shining light from a laser under the skin, this technology can measure blood sugar levels without the need for pricking the skin with a needle. This revolutionary approach not only benefits diabetics who can now test their blood sugar levels painlessly, but it also has the potential to detect pre-diabetes and other blood sugar-related issues.
Earlier this year, Apple reportedly achieved a groundbreaking “proof of concept” stage utilizing hardware roughly the size of an iPhone. However, there are significant technical challenges ahead in reducing the size of the hardware to fit into the small and sleek design of the Apple Watch.
Industry expert Mark Gurman from Bloomberg News speculates that it may take approximately 3 to 7 years before Apple’s non-invasive blood sugar measurement technology becomes commercially available. The company continues to prioritize the development of this cutting-edge technology, which has the potential to revolutionize healthcare monitoring for millions of individuals worldwide.
On the 14th (local time), multiple foreign media outlets reported, citing Bloomberg News, that Apple appointed Tim Millet, vice president of platform architecture, as the new head of the Apple Watch series blood sugar measurement development team.
According to reports, Apple’s non-invasive blood sugar measurement technology is being developed by XDG (Exploratory Design Group), a secret research organization. There are several projects within XDG, and Millett will lead the project to develop non-invasive blood glucose measurement. Bill Athas, who previously led the development team, died unexpectedly at the end of 2022.
Millett has been with Apple for almost 20 years. In particular, Millett is said to have played a key role in the transition to Apple Silicon by leading several teams working on processors.
Apple’s non-invasive blood sugar measurement technology is understood to use a silicon photonics chip that can measure blood sugar levels by shining light from a laser under the skin using optical absorption spectroscopy without needing to pierce the skin with a needle.
Non-invasive blood sugar measurement technology allows diabetics to test their blood sugar levels without pricking their skin with a needle, and can also detect pre-diabetes and other blood sugar problems.
Earlier this year, Apple reportedly reached an innovative “proof of concept” stage using hardware around the size of an iPhone, but many technical challenges remain in shrinking the hardware down to the size of a module that can fit into a small, thin package of the Apple Watch name. .
Mark Gurman of Bloomberg News predicted in a previous report that it would take about 3 to 7 years for Apple’s non-invasive blood sugar measurement technology to be commercialized.
#Apple #Watch #Series #Accelerates #Development #NonInvasive #Blood #Sugar #Measurement #Technology
